ECSP10010327A - Péptidos del fviii y su uso para hemofílicos tolerantes - Google Patents
Péptidos del fviii y su uso para hemofílicos tolerantesInfo
- Publication number
- ECSP10010327A ECSP10010327A EC2010010327A ECSP10010327A ECSP10010327A EC SP10010327 A ECSP10010327 A EC SP10010327A EC 2010010327 A EC2010010327 A EC 2010010327A EC SP10010327 A ECSP10010327 A EC SP10010327A EC SP10010327 A ECSP10010327 A EC SP10010327A
- Authority
- EC
- Ecuador
- Prior art keywords
- peptides
- fviii
- hemophylics
- tolerant
- peptide
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 title abstract 3
- 102100026735 Coagulation factor VIII Human genes 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 201000003542 Factor VIII deficiency Diseases 0.000 abstract 1
- 208000009292 Hemophilia A Diseases 0.000 abstract 1
- 208000013633 acquired hemophilia Diseases 0.000 abstract 1
- 230000030741 antigen processing and presentation Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 102000057593 human F8 Human genes 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000001629 suppression Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0723712.6A GB0723712D0 (en) | 2007-12-04 | 2007-12-04 | Peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP10010327A true ECSP10010327A (es) | 2010-09-30 |
Family
ID=38982965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2010010327A ECSP10010327A (es) | 2007-12-04 | 2010-07-02 | Péptidos del fviii y su uso para hemofílicos tolerantes |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8445448B2 (https=) |
| EP (1) | EP2227488B3 (https=) |
| JP (2) | JP5501245B2 (https=) |
| KR (1) | KR101519840B1 (https=) |
| CN (2) | CN101889024B (https=) |
| AU (1) | AU2008332968B2 (https=) |
| BR (1) | BRPI0820143A2 (https=) |
| CA (2) | CA3005013C (https=) |
| CY (1) | CY1115168T1 (https=) |
| DK (1) | DK2227488T6 (https=) |
| EA (1) | EA019370B1 (https=) |
| EC (1) | ECSP10010327A (https=) |
| ES (1) | ES2458315T7 (https=) |
| GB (1) | GB0723712D0 (https=) |
| HR (1) | HRP20140344T4 (https=) |
| IL (1) | IL205780A (https=) |
| MX (1) | MX2010006084A (https=) |
| MY (1) | MY150995A (https=) |
| NZ (1) | NZ585217A (https=) |
| PL (1) | PL2227488T6 (https=) |
| PT (1) | PT2227488E (https=) |
| SI (1) | SI2227488T1 (https=) |
| UA (1) | UA101003C2 (https=) |
| WO (1) | WO2009071886A1 (https=) |
| ZA (1) | ZA201002997B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102764425B (zh) | 2000-08-21 | 2015-11-25 | 阿皮托普技术(布里斯托尔)有限公司 | 肽选择方法 |
| GB0801513D0 (en) * | 2008-01-28 | 2008-03-05 | Circassia Ltd | Peptides from factor VIII |
| EP2300497B1 (en) * | 2008-06-24 | 2012-08-08 | Octapharma AG | A process of purifying coagulation factor viii |
| GB0908515D0 (en) * | 2009-05-18 | 2009-06-24 | Apitope Technology Bristol Ltd | Peptide |
| CA2765657A1 (en) * | 2009-06-16 | 2010-12-23 | Tokai University | Anti-gram-negative bacteria agent |
| EP2632479B1 (en) * | 2010-10-27 | 2017-06-14 | Baxalta GmbH | Fviii peptides for immune tolerance induction and immunodiagnostics |
| EA038705B1 (ru) | 2012-01-12 | 2021-10-07 | Биовератив Терапьютикс Инк. | Способы снижения иммуногенности фактора свёртывания крови viii у пациентов, получающих лечение фактором viii |
| EA036483B1 (ru) * | 2012-11-12 | 2020-11-16 | Эпитоп Интернэшнл Нв | Пептиды, способные индуцировать толерантность к рекомбинантному fviii, содержащая их композиция, их применение и способ лечения гемофилии |
| GB201314052D0 (en) * | 2013-08-06 | 2013-09-18 | Apitope Int Nv | Peptides |
| EP4212547A1 (en) | 2015-12-03 | 2023-07-19 | Juno Therapeutics, Inc. | Modified chimeric receptors and related compositions and methods |
| JP2019536794A (ja) | 2016-12-02 | 2019-12-19 | バイオベラティブ セラピューティクス インコーポレイテッド | 凝固因子に対する免疫寛容を誘導する方法 |
| US12077607B2 (en) * | 2021-09-23 | 2024-09-03 | University Of Utah Research Foundation | Functional and therapeutic effects of PAR4 cleavage by cathepsin G |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE902211A1 (en) * | 1989-06-20 | 1991-01-16 | Scripps Clinic Res | The phospholipid binding domain of factor viii |
| WO1998031394A2 (en) * | 1997-01-22 | 1998-07-23 | Board Of Regents, The University Of Texas System | Tissue factor methods and compositions for coagulation and tumor treatment |
| CN102764425B (zh) * | 2000-08-21 | 2015-11-25 | 阿皮托普技术(布里斯托尔)有限公司 | 肽选择方法 |
| AU2002249779A1 (en) * | 2000-12-01 | 2002-08-12 | Regents Of The University Of Minnesota | Method to treat hemophilia |
| CN100522242C (zh) * | 2001-02-19 | 2009-08-05 | 默克专利有限公司 | 具有降低的免疫原性的人工蛋白质 |
| WO2002098454A2 (en) | 2001-05-31 | 2002-12-12 | D. Collen Research Foundation Vzw Onderwijsen Navorsing Campus Gasthuisberg K.U. Leuven | Recombinant molecules with reduced immunogenicity, methods and intermediates for obtaining them and their use in pharmaceutical compositions and diagnostic tools |
| WO2003087161A1 (en) | 2002-04-18 | 2003-10-23 | Merck Patent Gmbh | Modified factor viii |
| HUE027902T2 (en) * | 2004-02-09 | 2016-11-28 | Human Genome Sciences Inc Corp Service Company | Albumin fusion proteins |
| WO2006003183A1 (de) | 2004-07-02 | 2006-01-12 | Alois Jungbauer | Peptide zur blockierung von fviii-inhibitoren |
| IL229645A0 (en) * | 2013-11-26 | 2014-03-31 | Omrix Biopharmaceuticals Ltd | A dry bandage containing thrombin and pectin |
-
2007
- 2007-12-04 GB GBGB0723712.6A patent/GB0723712D0/en not_active Ceased
-
2008
- 2008-03-12 UA UAA201008194A patent/UA101003C2/uk unknown
- 2008-12-03 CN CN200880119313.1A patent/CN101889024B/zh not_active Expired - Fee Related
- 2008-12-03 BR BRPI0820143 patent/BRPI0820143A2/pt not_active Application Discontinuation
- 2008-12-03 JP JP2010536523A patent/JP5501245B2/ja not_active Expired - Fee Related
- 2008-12-03 DK DK08855772.3T patent/DK2227488T6/en active
- 2008-12-03 EP EP08855772.3A patent/EP2227488B3/en active Active
- 2008-12-03 MX MX2010006084A patent/MX2010006084A/es active IP Right Grant
- 2008-12-03 EA EA201070681A patent/EA019370B1/ru not_active IP Right Cessation
- 2008-12-03 SI SI200831186T patent/SI2227488T1/sl unknown
- 2008-12-03 WO PCT/GB2008/003996 patent/WO2009071886A1/en not_active Ceased
- 2008-12-03 MY MYPI20102567 patent/MY150995A/en unknown
- 2008-12-03 KR KR1020107011743A patent/KR101519840B1/ko not_active Expired - Fee Related
- 2008-12-03 PT PT88557723T patent/PT2227488E/pt unknown
- 2008-12-03 US US12/746,141 patent/US8445448B2/en not_active Expired - Fee Related
- 2008-12-03 ES ES08855772.3T patent/ES2458315T7/es active Active
- 2008-12-03 CA CA3005013A patent/CA3005013C/en active Active
- 2008-12-03 HR HRP20140344TT patent/HRP20140344T4/hr unknown
- 2008-12-03 NZ NZ585217A patent/NZ585217A/xx not_active IP Right Cessation
- 2008-12-03 CA CA2707559A patent/CA2707559C/en active Active
- 2008-12-03 CN CN201310392152.6A patent/CN103709234B/zh not_active Expired - Fee Related
- 2008-12-03 PL PL08855772T patent/PL2227488T6/pl unknown
- 2008-12-03 AU AU2008332968A patent/AU2008332968B2/en not_active Ceased
-
2010
- 2010-04-29 ZA ZA2010/02997A patent/ZA201002997B/en unknown
- 2010-05-13 IL IL205780A patent/IL205780A/en active IP Right Grant
- 2010-07-02 EC EC2010010327A patent/ECSP10010327A/es unknown
-
2014
- 2014-02-10 JP JP2014023217A patent/JP6063402B2/ja not_active Expired - Fee Related
- 2014-04-15 CY CY20141100281T patent/CY1115168T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP10010327A (es) | Péptidos del fviii y su uso para hemofílicos tolerantes | |
| CY1122458T1 (el) | Αντισωματα αντι-n3pglu αμυλοειδους βητα πεπτιδιου και χρησεις αυτων | |
| EA201592264A1 (ru) | Композиции, которые индуцируют хелперное действие т-клеток | |
| EA201070271A1 (ru) | Пептиды для получения вакцины | |
| UA103751C2 (ru) | Иммуногенный пептид для иммунотерапии | |
| PE20120170A1 (es) | Variantes de union a anti-albumina de suero mejoradas | |
| CL2008002092A1 (es) | Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas. | |
| EA200701305A1 (ru) | Иммуногенные композиции, содержащие циклические пептиды, полученные из бета-амилоидного пептида | |
| EP2403871A4 (en) | FOR ABUSED PRION PROTEIN SPECIFIC ANTIBODIES AND EPITOPES | |
| CO6460780A2 (es) | Péptido | |
| CY1114618T1 (el) | Βιολογικα δραστικα πεπτιδια που περιεχουν καρβοξυτελικη αργινινη | |
| MX2011007963A (es) | Peptidos neil3 y vacunas que incluyen los mismos. | |
| EA201171001A1 (ru) | Пептиды трав для вакцины | |
| PH12015501033A1 (en) | Peptides | |
| UA97092C2 (ru) | T-клеточные эпитопы с раково-эмбрионального антиген-незрелого рецепторного белка ламинина и их медицинское применение | |
| WO2009053535A3 (en) | Peptide vaccine for influenza virus | |
| MX2013004417A (es) | Peptidos wdhd1 y vacunas que los incluyen. | |
| TH130487A (th) | เพปไทด์ที่อนุพัทธ์มาจากแฟคเตอร์ viii | |
| UA114015C2 (xx) | Пептид | |
| CY1117265T1 (el) | Αντισωματα aνti-n3pglu αμυλοειδους βητα πεπτιδιου και χρησεις αυτων | |
| EA201992367A1 (ru) | Вакцины на основе пептидов, способы их изготовления и применения для индуцирования иммунного ответа |